Clinical Trials Logo
  1. Home
  2. Severe Depression
  3. NCT02715986

Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy — ECT-IM  

Severe Depression Clinical Trial

Official title:
Structural-functional Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy: an Exploratory Study

Clinical Trial Summary

Electroconvulsive therapy (ECT) is a non-pharmacological treatment used in resistant depression whose effectiveness has been demonstrated. However, the brain mechanisms underlying this therapeutic effect remain unclear. Many animal studies show a neurotrophic action of ECT on the hippocampus: increased neurogenesis, synaptogenesis, proliferation of glial cells. In addition, functional imaging of "resting state" type have shown, among depressed patients after ECT, increased functional connectivity . These results were reinforced by the recent work of Perrin (2012). In view of this a priori contradictory, it seems appropriate to continue research neuroanatomical correlates subtending neurofunctional processes responsible at the same time improving the clinical depressive. The investigators suggest using an original technique never used in this type of population: Functional magnetic resonance imaging (fMRI) or multimodal structural-functional. This method will allow us to study the impact of ECT on brain structures involved in major depressive disorder: hippocampus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02715986
Study type Interventional
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date April 2016
Completion date July 2018
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03380442 - Psilocybin and Depression Phase 2
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Completed NCT02957591 - Probiotic Supplementation in Severe Depression N/A
Recruiting NCT05842278 - The Dosage Effect of pBFS Guided rTMS Treatment for MDD N/A
Not yet recruiting NCT05957341 - pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD N/A
Recruiting NCT05964036 - pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive Disorder N/A
Recruiting NCT03862209 - Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia N/A
Active, not recruiting NCT03837340 - Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health N/A
Active, not recruiting NCT03892473 - Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E ) N/A
Enrolling by invitation NCT03922425 - Community-based Mental Health Care for People With Severe and Enduring Mental III Health N/A
Recruiting NCT06112652 - Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique N/A
Completed NCT02522377 - Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression N/A